Tau Imaging in Alzheimer's: Comparing PET Tracers

We are comparing three different PET tau tracers in volunteers to see which one best measures tau levels in the brain. This research may help improve diagnosis and treatment monitoring for Alzheimer's disease.

>2 years Efficacy phase (II)No Placebo Investigational Medicines InjectionNeurologyOtolaryngology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Fludeoxyglucose (18f)

Fludeoxyglucose (18F) is a substance used in PET scans to help find and monitor cancer and other health problems.

Vizamyl

Vizamyl is a medicine used during PET brain scans to help detect deposits linked to Alzheimer’s disease.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Flortaucipir (18f)

Flortaucipir (18F) is a radioactive imaging tracer used in PET scans to visualize tau protein build-up in the brain.

Fludeoxyglucose (18f)

Fludeoxyglucose (18F) is a radioactive tracer used in PET scans to highlight areas of high metabolic activity, often for detecting cancer.

Flutemetamol (18f)

Flutemetamol (18F) is a radioactive PET imaging agent used to detect amyloid plaques in the brain to help evaluate Alzheimer’s disease.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Florquinitau

Dipyrido[2,3-b:3′,4′-d]pyrrole

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

[18f] Fdg

[18f] Fdg Βιοκοσμοσ

[18f] Fludeoxyglucose Biont

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Hospital De La Santa Creu I Sant Pau

Neurology

Barbastro, Spain

Sponsor: Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.